EGRX
ProShare Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,674
| Closed | -$238K | – | 2322 |
|
|
2021
Q4 | $238K | Buy |
4,674
+90
| +2% | +$4.58K | ﹤0.01% | 1923 |
|
|
2021
Q3 | $256K | Sell |
4,584
-1,102
| -19% | -$61.5K | ﹤0.01% | 1665 |
|
|
2021
Q2 | $243K | Buy |
5,686
+768
| +16% | +$32.8K | ﹤0.01% | 2026 |
|
|
2021
Q1 | $205K | Buy |
4,918
+383
| +8% | +$16K | ﹤0.01% | 2028 |
|
|
2020
Q4 | $211K | Buy |
+4,535
| New | +$211K | ﹤0.01% | 1821 |
|
|
2020
Q1 | – | Sell |
-4,468
| Closed | -$268K | – | 1645 |
|
|
2019
Q4 | $268K | Sell |
4,468
-525
| -11% | -$31.5K | ﹤0.01% | 1411 |
|
|
2019
Q3 | $282K | Sell |
4,993
-485
| -9% | -$27.4K | ﹤0.01% | 1262 |
|
|
2019
Q2 | $305K | Sell |
5,478
-701
| -11% | -$39K | ﹤0.01% | 1232 |
|
|
2019
Q1 | $312K | Sell |
6,179
-298
| -5% | -$15K | ﹤0.01% | 1236 |
|
|
2018
Q4 | $261K | Sell |
6,477
-1,237
| -16% | -$49.8K | ﹤0.01% | 1229 |
|
|
2018
Q3 | $535K | Sell |
7,714
-164
| -2% | -$11.4K | ﹤0.01% | 1078 |
|
|
2018
Q2 | $596K | Sell |
7,878
-279
| -3% | -$21.1K | ﹤0.01% | 1036 |
|
|
2018
Q1 | $430K | Sell |
8,157
-1,329
| -14% | -$70.1K | ﹤0.01% | 1164 |
|
|
2017
Q4 | $507K | Buy |
9,486
+211
| +2% | +$11.3K | ﹤0.01% | 1125 |
|
|
2017
Q3 | $553K | Buy |
9,275
+577
| +7% | +$34.4K | 0.01% | 919 |
|
|
2017
Q2 | $686K | Sell |
8,698
-749
| -8% | -$59.1K | 0.01% | 846 |
|
|
2017
Q1 | $784K | Sell |
9,447
-2,348
| -20% | -$195K | 0.01% | 839 |
|
|
2016
Q4 | $936K | Buy |
11,795
+902
| +8% | +$71.6K | 0.01% | 806 |
|
|
2016
Q3 | $763K | Sell |
10,893
-1,830
| -14% | -$128K | 0.01% | 769 |
|
|
2016
Q2 | $494K | Buy |
12,723
+97
| +0.8% | +$3.77K | 0.01% | 970 |
|
|
2016
Q1 | $511K | Sell |
12,626
-1,160
| -8% | -$46.9K | 0.01% | 979 |
|
|
2015
Q4 | $1.22M | Buy |
+13,786
| New | +$1.22M | 0.01% | 664 |
|